Yiling Pharmaceutical Brand Ranking

Yiling Pharmaceutical

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Industry： Cold medicine , Gastric and digestive tablets , drug , Chinese patent medicine , Rhodiola

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Yiling Pharmaceutical

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Industry： Cold medicine , Gastric and digestive tablets , drug , Chinese patent medicine , Rhodiola

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Brand Introduction

Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded on June 16, 1992 (stock code 002603). The company takes "inheriting innovation and benefiting mankind" as its corporate purpose, "technology and health tomorrow" as its development goal, "seeking development for employees, Contributing to society and creating value for shareholders" is the business philosophy, always adhering to the innovative development strategy of science and technology and market leader, systematically constructing a theoretical system of network diseases, and creating a five-in-one "theory-clinical-scientific research-industry-teaching" The operating model has formed an industrial development cluster of "from medicine to medicine to health", and the "Traditional Chinese Medicine Cytopathy Diagnosis and Treatment Methods" have been included in the national intangible cultural heritage. "Cytopathy" has become a university textbook, with more than 40 institutes nationwide Colleges and universities start classes. It has successively undertaken more than 60 national and provincial and ministerial projects, including the National 973, National 863, National Natural Science Foundation, and National Key R&D Plan.

The company developed Tongxinluo Capsules for the treatment of coronary heart disease and cerebral infarction, Shensong Yangxin Capsules for the treatment of both fast and slow heart disease, Qili Qiangxin Capsules for the treatment of chronic heart failure, Lianhua Qingwen Capsules for the treatment of colds and anti-flu, and nourishing the kidneys. There are more than 10 patented new drugs such as Bazi Bushen Capsules, which have obtained more than 800 patents. 5 production and R&D bases have been built in Hebei and Beijing, and more than 30 raw material bases of traditional Chinese medicinal materials have been established across the country. The production workshop has successively passed international certifications in many countries and regions such as the United States, the European Union, Canada, and New Zealand. A comprehensive quality control system that complies with international standards. Lianhua Qingwen is listed in more than 30 countries.